Inflexion invests in European vaccine provider

Inflexion invests in European vaccine provider

Mid-market private equity firm Inflexion Private Equity has announced that it has completed a minority investment in European provider of vaccinations European LifeCare Group (ELCG). ELCG has more than 50 specialist clinics in Denmark and the UK, where it trades under a number of brands, including London Travel Clinic. It also works for both the Danish and English NHS as a contracted service provider of immunisation programmes in schools and national influenza vaccination programmes and is forecast to vaccinate approximately 400,000 individuals on behalf of the NHS in Denmark and the UK.

Simon Turner, Managing Partner of Inflexion, commented: “ELCG is a leading company in a rapidly growing niche market. The team has strong experience in building their business both through acquisitions and opening new clinics. It is the number one consolidator in a fragmented market which also has scope to benefit from additional clinic openings. We look forward to working with it to accelerate ELCG’s already impressive growth.”  

Karsten Østergaard, CEO and Co-Founder of ELCG, said: “We are proud of the company we have built, and now see a tremendous opportunity to accelerate our UK growth where we see the potential for over 100 of our vaccination clinics. Inflexion’s strong track record in sourcing and integrating add-on acquisitions makes it an excellent partner for us as we embark on this next phase of our journey.”